MedDataX Logo

A Study of the Effects of Molecular Diagnostic Directed Wound Gels on Wound Care Outcomes

NCT ID: NCT01319149

Last Updated: 2012-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-11-30

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A retrospective molecular diagnostic review on wound care outcomes. The time periods include March, April, May of 2010.The retrospective review would analyze the days of healing during the timeframe, upon the introduction of molecular diagnostic testing

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The null hypothesis would be that the introduction of molecular methods did not statistically affect patient outcomes. To study this hypothesis, our chief information technologist would query the database for any patients who are admitted during that time period. This period of time designated is March, April and May 2010.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wounds

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

molecular methods

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No treatment

Patient records would be extracted from the electronic health record system of Southwest Regional Wound Care Center and placed in a separate bin.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have been treated at SWRWCC during the months of March, April, or May 2010.

Exclusion Criteria

* Patients who were not treated at SWRWCC during the time frame of March, April or May 2010.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Southwest Regional Wound Care Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Randall Wolcott

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Randall D Wolcott, M.D.

Role: PRINCIPAL_INVESTIGATOR

Southwest Regional Wound Care Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southwest Regional Wound Care Center

Lubbock, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

56-RW-020

Identifier Type: -

Identifier Source: org_study_id